Cetuximab in Treating Patients With Anal Cancer

Links shared publicly online about this topic

Cetuximab Helps Treat Colorectal Cancer:

health.msn.com — “Cetuximab Helps Treat Colorectal Cancer:View full resource at health.msn.com

  • View Related
  • Share

Most Recently Shared on November 25, 2009 at 5:46 pm By:

msnhealthnews msn Health News

Cetuximab Helps Treat Colorectal Cancer: http://bit.ly/8Adnhc

2 years ago...

Cetuximab Helps Treat Colorectal Cancer - Drugs.com MedNews

drugs.com — “Adding the drug cetuximab to neoadjuvant chemotherapy can shrink tumors and boost the odds of successful surgery in colorectal cancer patients with inoperable mView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on November 25, 2009 at 9:30 pm By:

drugscom Drugs.com Health Site

Cetuximab Helps Treat Colorectal Cancer - http://bit.ly/6NSnsP

2 years ago...

Resectability With Cetuximab Extends Life In Difficult-to-Treat Metastatic Colorectal Cancer

medicalnewstoday.com — “Combining the epidermal growth factor receptor (EGFR) inhibitor cetuximab with conventional chemotherapy improves survival in patients who have had complete resection of colorectal liver metastaseView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 7, 2011 at 3:05 pm By:

mnt_healthnews MNT Health News Health News

Resectability With Cetuximab Extends Life In Difficult-to-Treat Metastatic Colorectal Cancer http://mnt.to/429C #healthnews

8 months ago...

Combining RNA Interference With Tyrosine Kinase Inhibitors Or Cetuximab Enhances Lung Cancer Therapy

medicalnewstoday.com — “Non-small cell lung cancer (NSCLC), the most common form of lung cancer, is usually treated with surgery and chemotherapy. However, a small group of patients can also be helped by treatment with tView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 21, 2012 at 8:05 am By:

LungCancer Lung Cancer OW OW Health

Combining RNA Interference With Tyrosine Kinase Inhibitors Or Cetuximab Enhances Lung Cancer Therapy: Non-small ... http://t.co/nfOz9EY5

2 months ago...

Combining Radiation Therapy, Chemotherapy Safely Treats Head And Neck Cancer Patients

medicalnewstoday.com — “Stereotactic body radiotherapy (SBRT), a radiation therapy procedure pioneered at the University of Pittsburgh Cancer Institute (UPCI) that precisely delivers a large dose of radiation to tumors,View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 5, 2010 at 2:05 pm By:

mnt_radiology MNT Radiology Health News

Combining Radiation Therapy, Chemotherapy Safely Treats Head And Neck Cancer Patients http://mnt.to/3M7G #radiology

2 years ago...

Combining radiation therapy, chemotherapy safely treats head and neck cancer patients

physorg.com — “Stereotactic body radiotherapy (SBRT), a radiation therapy procedure pioneered at the University of Pittsburgh Cancer Institute (UPCI) that precisely delivers a large dose of radiation to tumors, may effectively control and treat head and neck cancers when combined with the chemotherapy Cetuximab, according ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on November 3, 2010 at 9:07 pm By:

FightCancer FightCancer Health News

Combining radiation therapy, chemotherapy safely treats head and neck cancer patients http://bit.ly/ds0igI

2 years ago...

FDA approves Erbitux to treat late-stage head and neck cancer

fda.gov — “The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on November 7, 2011 at 7:27 pm By:

NCIBulletin NCI Cancer Bulletin Health News

FDA approves Erbitux, in combination w/ chemotherapy, to treat late-stage head & neck cancer (release) http://t.co/bMtFRAyA

7 months ago...

Non-AIDS-Related Cancers Growing Among HIV Patients - Drugs.com MedNews

drugs.com — “Non-AIDS-related cancers such as anal and lung cancer have become more common among HIV patients than among people without HIV since antiretroviral therapies weView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on September 30, 2009 at 10:17 pm By:

drugscom Drugs.com Health Site

Non-AIDS-Related Cancers Growing Among HIV Patients - http://bit.ly/jx1X3

3 years ago...

Colorectal cancer patients with gene mutation show better response to cancer agent

physorg.com — “Even though the cancer-treatment agent cetuximab is not considered effective treatment for KRAS (a gene)-mutated metastatic colorectal tumors, new research indicates that patients with colorectal cancer not responding to chemotherapy and a certain variation of this gene who were treated with cetuximab ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on October 26, 2010 at 9:38 pm By:

FightCancer FightCancer Health News

Colorectal cancer patients with gene mutation show better response to cancer agent http://bit.ly/dliF4z

2 years ago...

Colorectal Cancer Patients with Gene Mutation Show Better Response to Cancer Agent

newswise.com — “Even though the cancer-treatment agent cetuximab is not considered effective treatment for KRAS (a gene)-mutated metastatic colorectal tumors, new research indicates that patients with colorectal cancer not responding to chemotherapy and a certain variation of this gene who were treated with cetuximab had longer overall and progression-free survival than patients with other KRAS-mutations, according to a study in the October 27 issue of JAMA.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on October 26, 2010 at 8:43 pm By:

newswise newswise Health Communicator and Health News

Colorectal Cancer Patients with Gene Mutation Show Better Response to Cancer Agent: Even though the cancer-treatme... http://bit.ly/aPiu2x

2 years ago...

Data Presented From Two Phase 3 ERBITUX® Studies In First-Line Metastatic Colorectal Cancer Patients At Joint 15th European Cancer Organisation

medicalnewstoday.com — “According to a recent retrospective analysis of the pivotal Phase 3 CRYSTAL study, ERBITUX® (cetuximab), when added to FOLFIRI, was shown to increase median overall survival to 19.9 months inView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 26, 2009 at 11:42 am By:

mnt_clinical MNT Clinical Trials Health News

Data Presented From Two Phase 3 ERBITUX® Studies In First-Line Metastatic Colorectal Cancer Patients At Joint 1.. http://bit.ly/1Qiuhj

3 years ago...

Targeted therapy that benefits patients with metastatic colon cancer fails to help patients with stage III cancer

news-medical.net — “To the surprise of researchers at Mayo Clinic who led a national clinical trial, a targeted therapy that provides benefit to patients with metastatic colon cancer has failed to help patients with less advanced, stage III cancer. In fact, patients who used the agent, cetuximab, with chemotherapy had outcomes slightly inferior to patients treated with chemotherapy alone.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 7, 2010 at 5:08 pm By:

NewsMedical News-Medical.Net Health News

Targeted therapy that benefits patients with metastatic colon cancer fails to help patients with stage III cancer:... http://bit.ly/9ie5WF

2 years ago...

New Insights on Who Should Take Erbitux for Colon Cancer:

health.msn.com — “New Insights on Who Should Take Erbitux for Colon Cancer:View full resource at health.msn.com

  • View Related
  • Share

Most Recently Shared on October 26, 2010 at 8:47 pm By:

msnhealthnews msn Health News

New Insights on Who Should Take Erbitux for Colon Cancer: http://on-msn.com/czELx4

2 years ago...

New Insights on Who Should Take Erbitux for Colon Cancer - Drugs.com MedNews

drugs.com — “New research challenges previous assumptions about how to treat metastatic colon cancer in patients with a certain genetic mutation. While guidelines have recomView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 26, 2010 at 9:52 pm By:

drugscom Drugs.com Health Site

New Insights on Who Should Take Erbitux for Colon Cancer - http://bit.ly/9rUpZw

2 years ago...

New Insights on Who Should Take Erbitux for Colon Cancer - Drugs.com MedNews

drugs.com — “New research challenges previous assumptions about how to treat metastatic colon cancer in patients with a certain genetic mutation. While guidelines have recomView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 26, 2010 at 9:13 pm By:

Drugs_Devices Drugs and Devices OW OW Health

New Insights on Who Should Take Erbitux for Colon Cancer: TUESDAY, Oct. 26 -- New research challenges previou... http://bit.ly/bFoWJP #drug

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390